HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mengtao Li Selected Research

R333

12/2020JAK Inhibitors: Prospects in Connective Tissue Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mengtao Li Research Topics

Disease

29Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 09/2011
13Pulmonary Arterial Hypertension
11/2022 - 01/2014
12Thrombocytopenia (Thrombopenia)
06/2022 - 09/2011
10Inflammation (Inflammations)
03/2021 - 03/2012
6Autoimmune Diseases (Autoimmune Disease)
11/2022 - 01/2015
6Connective Tissue Diseases (Connective Tissue Disease)
11/2022 - 01/2015
6Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2022 - 01/2020
6Neoplasms (Cancer)
10/2021 - 07/2006
5Systemic Scleroderma (Systemic Sclerosis)
11/2021 - 01/2013
5Interstitial Lung Diseases (Interstitial Lung Disease)
11/2021 - 03/2016
5Arthritis (Polyarthritis)
10/2021 - 06/2014
5Infections
01/2021 - 01/2013
4Ankylosing Spondylitis
03/2022 - 01/2020
4Takayasu Arteritis (Arteritis, Takayasu's)
12/2020 - 12/2016
3Rheumatoid Arthritis
01/2022 - 06/2019
3Sjogren's Syndrome (Sjogren Syndrome)
01/2022 - 01/2015
3Fibrosis (Cirrhosis)
11/2021 - 01/2014
3Dermatomyositis (Dermatopolymyositis)
01/2021 - 11/2020
3Atherosclerosis
01/2021 - 06/2019
3Proteinuria
01/2021 - 01/2013
3Exanthema (Rash)
10/2019 - 03/2016
2Axial Spondyloarthritis
03/2022 - 01/2020
2Thrombosis (Thrombus)
01/2022 - 11/2021
2Fever (Fevers)
01/2022 - 03/2021
2Vasculitis (Vasculitides)
01/2022 - 12/2020
2Myositis (Idiopathic Inflammatory Myopathies)
11/2021 - 11/2020
2Pulmonary Hypertension
11/2021 - 08/2015
2Pain (Aches)
05/2021 - 10/2020
2Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021 - 10/2020
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2021 - 01/2015
2Opportunistic Infections (Opportunistic Infection)
01/2021 - 12/2020
2Rheumatic Diseases (Rheumatism)
01/2021 - 01/2017
2Gout
10/2020 - 10/2006
2Pericardial Effusion
08/2020 - 05/2018
2Lupus Nephritis
01/2020 - 01/2013
2Dry Eye Syndromes (Dry Eye Syndrome)
01/2020 - 07/2011
2Immunoglobulin G4-Related Disease
11/2015 - 01/2015
1Myocarditis (Carditis)
09/2022
1Lymphopenia (Lymphocytopenia)
06/2022
1Spondylarthropathies
03/2022
1Non-Radiographic Axial Spondyloarthritis
03/2022
1Heart Valve Diseases (Valvular Heart Disease)
02/2022
1Transverse Myelitis (Necrotizing Myelitis)
02/2022
1Myelitis
02/2022
1Retinal Vein Occlusion
02/2022
1Retinal Artery Occlusion
02/2022
1Thrombotic Microangiopathies
02/2022
1Asthma (Bronchial Asthma)
01/2022
1Psoriatic Arthritis
01/2022

Drug/Important Bio-Agent (IBA)

13AntibodiesIBA
09/2022 - 03/2012
8Immunosuppressive Agents (Immunosuppressants)IBA
09/2022 - 09/2011
8AutoantibodiesIBA
05/2022 - 01/2014
8C-Reactive ProteinIBA
01/2022 - 06/2014
5Antiphospholipid AntibodiesIBA
11/2022 - 01/2020
5Immunoglobulin G (IgG)IBA
05/2022 - 01/2015
5Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2006
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 10/2006
5Biological ProductsIBA
01/2021 - 07/2006
4Proteins (Proteins, Gene)FDA Link
05/2022 - 10/2017
4Phospholipids (Phosphatides)FDA LinkGeneric
08/2021 - 07/2015
4tofacitinibIBA
01/2021 - 10/2019
3Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2022 - 11/2021
3HLA-B27 Antigen (HLA B27 Antigen)IBA
03/2022 - 01/2020
3Adalimumab (Humira)FDA Link
03/2022 - 01/2020
3Biosimilar PharmaceuticalsIBA
03/2022 - 01/2020
3Tacrolimus (Prograf)FDA LinkGeneric
01/2022 - 01/2013
3Sirolimus (Rapamycin)FDA Link
01/2022 - 01/2020
3Immunoglobulin A (IgA)IBA
01/2022 - 01/2020
3Uric Acid (Urate)IBA
11/2021 - 10/2006
3Rituximab (Mabthera)FDA Link
01/2021 - 09/2011
3GlucocorticoidsIBA
08/2020 - 09/2011
3Rheumatoid FactorIBA
01/2020 - 07/2011
37-(N-(3-aminopropyl)amino)heptan-2-oneIBA
11/2019 - 01/2014
2beta-cyclodextrin tetradecasulfate (CTDS)IBA
11/2022 - 12/2020
2Nucleosomes (Nucleosome)IBA
09/2022 - 11/2020
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
06/2022 - 06/2019
2Immunoglobulin M (IgM)IBA
05/2022 - 01/2021
2ametantrone (HAQ)IBA
03/2022 - 10/2020
2Monoclonal AntibodiesIBA
01/2022 - 11/2016
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022 - 03/2021
2baricitinibIBA
01/2022 - 12/2020
2MicroRNAs (MicroRNA)IBA
11/2021 - 03/2013
2Indicators and Reagents (Reagents)IBA
11/2021 - 01/2020
2CytokinesIBA
01/2021 - 12/2020
2AutoantigensIBA
01/2021 - 01/2021
2Toll-Like Receptor 7IBA
01/2021 - 01/2019
2tocilizumab (atlizumab)FDA Link
01/2021 - 03/2017
2InterleukinsIBA
01/2021 - 01/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 10/2017
2EnzymesIBA
11/2020 - 03/2017
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2020 - 01/2013
2Immunoglobulins (Immunoglobulin)IBA
01/2020 - 03/2010
2AntigensIBA
07/2015 - 05/2012
2Interleukin-17 (Interleukin 17)IBA
01/2014 - 01/2013
1Retinaldehyde (Retinal)IBA
02/2022
1Complement System Proteins (Complement)IBA
02/2022
1N-phthaloylglutamic acidIBA
01/2022
1Peroxidase (Myeloperoxidase)IBA
01/2022
1HLA-A Antigens (HLA-A)IBA
01/2022

Therapy/Procedure

12Therapeutics
02/2022 - 09/2011